{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:56Z","timestamp":1760188136159},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":480,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002\u2003<\/jats:bold> Stern N, Grosskopf I, Shapira I, Kisch E, Isaacov A, Limor R, Baz M, Leshem Y, Flatau E, Miller A, Greenman Y (Tel Aviv University, Tel Aviv; Kupat Holim Klalit, Tel Aviv; Haemek Hospital, Afula; and Kupat Holim Klalit, Afula, Israel). Risk factor clustering in hypertensive patients: impact of the reports of NCEP\u2010II and second joint task force on coronary prevention on JNC\u2010VI guidelines. <jats:italic>J Intern Med<\/jats:italic> 2000; <jats:bold>248<\/jats:bold>: 203\u2013210.<\/jats:p><jats:p><jats:bold>Introduction.\u2002\u2003<\/jats:bold> Although the association of hypertension with established risk factors has been noted in several population studies, the recent redefinition of dyslipidaemia, hypertension and diabetes calls for reassessment of the prevalence and pattern of risk factor clusters in essential hypertension.<\/jats:p><jats:p><jats:bold>Objective.\u2002\u2003<\/jats:bold> To analyse the risk factor profile of Israeli patients with essential hypertension seen by primary care physicians and in hypertension specialty clinics, based on current definitions of dyslipidaemia hypertension and diabetes and JNC\u2010VI guidelines for the assessment of risk factors.<\/jats:p><jats:p><jats:bold>Design and Setting.\u2002\u2003<\/jats:bold> We analysed the risk profile of 324 Israeli hypertensive subjects using the JNC\u2010VI risk table and risk grouping. A total of 122 consecutive patients were recruited from primary care clinics and 212 consecutive patients were recruited from a hospital based hypertension clinic.<\/jats:p><jats:p><jats:bold>Results.\u2002\u2003<\/jats:bold> Amongst hypertensive individuals with no known target organ damage, only 1.5% had no risk factors other than hypertension, whereas all hypertensives with coronary artery disease had additional risk factors. Of the six listed major JNC\u2010VI risk factors (smoking, dyslipidaemia, diabetes, age, sex, family history of cardiovascular disease), hypertensive subjects without coronary artery disease (coronary artery disease\u2010negative) had 3.02\u2003\u00b1\u20030.10 risk factors, whereas hypertensive subjects with coronary artery disease (coronary artery disease\u2003positive) had 3.6\u2003\u00b1\u20030.07 risk factors other than hypertension (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Dyslipidaemia defined by NCEP\u2010II criteria was the most common associated risk factor identified in 93% of coronary artery disease\u2010positive and 77% of the coronary artery disease\u2010negative hypertensive subjects. The most common dyslipidaemic abnormality was an increased LDL cholesterol (79.2% of the cohort), followed by hypertriglyceridaemia (31.7%) and low HDL cholesterol (22.3%). Nevertheless, in nearly half of the coronary artery disease\u2010negative patients, LDL cholesterol concentrations were within 30\u2003mg\u2003dL<jats:sup>\u20131<\/jats:sup> of the target levels. The most common dyslipidaemic variant was isolated hypercholesterolaemia (42%), whereas the syndrome X dyslipidaemic combination of hypertriglyceridaemia and low HDL was strikingly uncommon, observed in 2.8% of the coronary artery disease\u2010positive and 0.8% of the coronary artery disease\u2010negative patients.<\/jats:p><jats:p><jats:bold>Conclusions.\u2002\u2003<\/jats:bold> (i) JNC\u2010VI group risk A patients (no risk factors) comprise a very small minority in this cohort (&lt;\u20035%); (ii) dyslipidaemia is exceedingly common with mild hypercholesterolaemia being the most prevalent variant and hypertriglyceridaemia with low HDL the least common form.<\/jats:p>","DOI":"10.1046\/j.1365-2796.2000.00724.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:12:05Z","timestamp":1047449525000},"page":"203-210","source":"Crossref","is-referenced-by-count":15,"title":["Risk factor clustering in hypertensive patients: impact of the reports of NCEP\u2010II and second joint task force on coronary prevention on JNC\u2010VI guidelines"],"prefix":"10.1111","volume":"248","author":[{"given":"N.","family":"Stern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Grosskopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Isaacov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Limor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Leshem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Flatau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Greenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajh\/7.7.7S","article-title":"Established risk factors and coronary artery disease: the Framingham study.","volume":"7","author":"Wilson PWF.","year":"1994","journal-title":"Am J Hypertens"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816100-00003"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90345-3"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199508001-00001"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.20.1.38"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00604.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.24.3579"},{"key":"e_1_2_5_9_2","first-page":"S35","article-title":"Clinical benefits of a consistent reduction in blood pressure.","volume":"16","author":"Mancia G","year":"1998","journal-title":"J Hypertens"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archinte.1992.00400130082009","article-title":"Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease; overall findings and differences by age for 316099 white men.","volume":"152","author":"Neaton JD","year":"1992","journal-title":"Arch Int Med"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.1.152"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.4.1305"},{"key":"e_1_2_5_13_2","first-page":"3015","article-title":"Summary of the second report of the National Cholesterol Education Program (NCEP).","volume":"269","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_5_14_2","first-page":"2413","article-title":"The sixth report of the Joint National Committee on prevention, detection evaluation and treatment of high blood pressure.","volume":"159","year":"1997","journal-title":"Arch Int Med"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1183"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-2-199801150-00002"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199003001-00003"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)90779-2"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.6.M252"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.60.2.427"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.5.605"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/oxfordjournals.aje.a112683","article-title":"High density lipoprotein cholesterol and incidence of coronary artery disease \u2013 The Israeli Ischemic Heart Disease Study.","volume":"109","author":"Goldbrut U","year":"1979","journal-title":"An J Epidemiol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)90735-4"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","unstructured":"PerryHM WrightJtJr ProschanM CushmanWC PresselS GrimmRH BlackHR LaRosaJ HawkinsCM WheltonPK DavisBR AldermanMH CutlerJA FordCE GordonDJ OparilS FurbergCD FrancisC.Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).Am J Hyperten1996;9(Part 1) : 342\u2013360.","DOI":"10.1016\/0895-7061(96)00037-4"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.2000.00724.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.2000.00724.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:26:57Z","timestamp":1698604017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.2000.00724.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1365-2796.2000.00724.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.2000.00724.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}